XM6TH1ICD-11 MMS 2026-01
Artemether and Lumefantrine
Description
Artemisinin-based combination of artemether + lumefantrine used for the prophylaxis and treatment of uncomplicated falciparum malaria.
Index terms
- Artemether and Lumefantrine
- Artemether + Lumefantrine
- Artemether-Lumefantrine
Sibling codes
XM0346– PentaquineXM08Q1– Pamaquine (naphthoate)XM0KE4– ChlorproguanilXM0NC8– AmopyroquinXM0RU7– QuinocideXM0VE8– Anti-infective antiprotozoal bloodXM0XQ2– PyrimethamineXM10R3– QuinacrineXM17W0– IsopentaquineXM1914– AntimalarialXM23A5– GuanatolXM37R2– Anti-infective antimalarialXM38E0– CinchonaXM3B54– Arterolane and PiperaquineXM3T26– HalofantrineXM50C8– AminoquinolinesXM50J2– MefloquineXM5Q32– Antimalarial pyrimidine derivativeXM5SP0– Artemisinin and derivatives, plainXM5WN6– Antimalarial prophylacticXM6M61– 8-Aminoquinoline drugsXM7LP3– Antiprotozoal drug bloodXM8H63– NaphthoquineXM8RC3– QuinineXM90Z4– Pyrimethamine with sulfadoxineXM9511– DaraprimXM9V39– Cinchonine alkaloidsXM9Z81– Schizontocide (blood) (tissue)
Foundation entity
Artemether and Lumefantrine – http://id.who.int/icd/entity/803036311
Part of: XM5MU9: Systemic antibiotics, anti-infectives or antiparasitics › XM6S30: Medicaments › X: Extension Codes